This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Masarykuv Onkologicky Ustav, Univerzita Palackeho V Olomouci, Lekarska Fakulta. Active years: 2013.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2013
Title: Lenka Radova: Innovator in Cancer Therapy Sensitivity Determination
Introduction
Lenka Radova is a notable inventor based in Otinoves, Czech Republic. She has made significant contributions to the field of cancer therapy through her innovative methods. Her work focuses on improving the sensitivity determination of patients suffering from cancer, which is crucial for effective treatment.
Latest Patents
Lenka Radova holds a patent for a method that determines the sensitivity of patients suffering from cancer to biological therapy. This invention relates to assessing the sensitivity of patients towards targeted biological therapy by inhibiting signaling pathways of the HER family members, such as HER-1, HER-2, HER-3, and HER-4. The method involves determining the expression of the biomarker S6 kinase or its post-translationally modified forms in tumors. This innovative approach aims to enhance the effectiveness of cancer treatments.
Career Highlights
Throughout her career, Lenka Radova has worked with several esteemed institutions, including Palacký University Olomouc, the Faculty of Medicine, and Masaryk Memorial Cancer Institute. Her dedication to research and development in the medical field has positioned her as a key figure in cancer therapy innovation.
Collaborations
Lenka has collaborated with notable colleagues such as Marian Hajduch and Marta Dziechciarkova. These partnerships have furthered her research and contributed to advancements in cancer treatment methodologies.
Conclusion
Lenka Radova's contributions to cancer therapy through her innovative patent demonstrate her commitment to improving patient outcomes. Her work continues to influence the field and offers hope for more effective cancer treatments in the future.